Biological Therapy Analysis & Statistics, January 2015 (p2)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

31-60 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Notch Signaling Pathway in Oncology Drug Pipeline Update 2015

Notch Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 266 companies plus partners ...

  • Industries : Biological Therapy
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 261 companies plus partners developing ...

  • Industries : Biological Therapy
TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

TGF-Beta Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

The TGF-beta receptor signaling pathway activates the MAPK/SMAD signaling modules. There are today 305 companies plus partners developing 367 TGF-beta receptor pathway targeting drugs in 1529 developmental ...

  • Industries : Biological Therapy
TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2015

TNF-Alpha Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

The TNF-alfa signaling pathway stimulates the MAPK signaling module and activates NFkB. There are today 386 companies plus partners developing 507 TNF-alpha pathway targeting drugs in 2119 developmental ...

  • Industries : Biological Therapy
Wnt Signaling Pathway in Oncology Drug Pipeline Update 2015

Wnt Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Abnormalities in the Wnt signaling pathway are associated with a large variety of human malignancies including tumors of breast, colon, pancreas, liver and bone. There are today 186 companies plus partners ...

  • Industries : Biological Therapy
Cancer Stem Cells Drug Pipeline Update 2015

Cancer Stem Cells Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which ...

  • Industries : Biological Therapy
Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2015

Interfering With Cytokine-Cytokine Receptor Interaction for the Treatment of Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

Cytokines are soluble extracellular proteins or glycoproteins that are crucial intercellular regulators and mobilizers of cells engaged in innate as well as adaptive inflammatory host defenses, cell growth, ...

  • Industries : Biological Therapy
Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

BioSeeker's Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and fast ...

  • Industries : Biological Therapy
DaVinci Biosciences, LLC - Product Pipeline Review - 2014

DaVinci Biosciences, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

DaVinci Biosciences, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘DaVinci Biosciences, LLC - Product Pipeline Review - 2014', provides an overview of the DaVinci Biosciences, ...

  • Industries : Biological Therapy
  • Countries : World
NeoStem, Inc. - Product Pipeline Review - 2014

NeoStem, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

NeoStem, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘NeoStem, Inc. - Product Pipeline Review - 2014', provides an overview of the NeoStem, Inc.'s pharmaceutical research and ...

  • Industries : Biological Therapy
  • Countries : World
Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering ...

  • Industries : Biological Therapy
Gene Therapy Dermatology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Dermatology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Dermatology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene ...

  • Industries : Biological Therapy
Gene Therapy Genito Urinary System And Sex Hormones Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Genito Urinary System And Sex Hormones Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Genito Urinary System and Sex Hormones Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy ...

  • Industries : Biological Therapy
Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 1 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Ear Nose Throat Disorders Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain ...

  • Industries : Biological Therapy
ID Signaling Pathway in Oncology Drug Pipeline Update 2015

ID Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 749
  • Industry report
  • January 2015
  • by Bioseeker

Inhibitor of DNA binding (ID) proteins are members of the helix-loop-helix (HLH) family of proteins which lack a DNA binding domain themselves but bind to other family members inhibiting their DNA binding ...

  • Industries : Biological Therapy
Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

BIONET Corp. (Symbol:1784) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Taiwan
Cellectis S.A. (Symbol:ALCLS) SWOT Analysis, Strategy, Revenues and Profits

Cellectis S.A. (Symbol:ALCLS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : France
International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

Protokinetix Inc. (Symbol:PKTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Canada
CHA Bio & Diostech Co., Ltd. (Symbol:085660) SWOT Analysis, Strategy, Revenues and Profits

CHA Bio & Diostech Co., Ltd. (Symbol:085660) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Japan Tissue Engineering Co., Ltd. (Symbol:7774) SWOT Analysis, Strategy, Revenues and Profits

Japan Tissue Engineering Co., Ltd. (Symbol:7774) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Japan
Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Mesoblast Limited (Mesoblast) is a biotechnology company. The company focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. ...

  • Industries : Biological Therapy
  • Countries : Australia, Singapore, Japan
MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

MediPost Co., Ltd. (Symbol:078160) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Belgium, Spain
Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Australia
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company's services include cell therapy. Its cell therapy is developing a novel cell-based therapy ...

  • Industries : Biological Therapy
  • Countries : United States
Pharmicell Co., Ltd. (005690) - Financial and Strategic SWOT Analysis Review

Pharmicell Co., Ltd. (005690) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Pharmicell Co., Ltd. (Pharmicell) is a biotechnology company. The company develops and commercializes stem cell therapeutics for incurable diseases such as cancer, brain and nervous system disorde ...

  • Industries : Biological Therapy

34 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.